Progressive aphasia secondary to Alzheimer disease vs FTLD pathology.

Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Abstract Text:

K A Josephs,J L Whitwell,J R Duffy,W A Vanvoorst,E A Strand,W T Hu,B F Boeve,N R Graff-Radford,J E Parisi,D S Knopman,D W Dickson,C R Jack,R C Petersen,K A Josephs,J L Whitwell,J R Duffy,W A Vanvoorst,E A Strand,W T Hu,B F Boeve,N R Graff-Radford,J E Parisi,D S Knopman,D W Dickson,C R Jack,R C Petersen,K A Josephs,J L Whitwell,J R Duffy,W A Vanvoorst,E A Strand,W T Hu,B F Boeve,N R Graff-Radford,J E Parisi,D S Knopman,D W Dickson,C R Jack,R C Petersen,

BACKGROUND: The pathology causing progressive aphasia is typically a variant of frontotemporal lobar degeneration, especially with ubiquitin-positive inclusions (FTLD-U). Less commonly the underlying pathology is Alzheimer disease (AD). OBJECTIVE: To compare clinicopathologic and MRI features of subjects with progressive aphasia and AD pathology to subjects with aphasia and FTLD-U pathology and subjects with typical AD. METHODS: We identified 5 subjects with aphasia and AD pathology and 5 with aphasia and FTLD-U pathology with an MRI from a total of 216 aphasia subjects. Ten subjects with typical AD clinical features and AD pathology were also identified. All subjects with AD pathology underwent pathologic reanalysis with TDP-43 immunohistochemistry. Voxel-based morphometry (VBM) was used to assess patterns of gray matter atrophy in the aphasia cases with AD pathology, aphasia cases with FTLD-U, and typical AD cases with AD pathology, compared with a normal control group. RESULTS: All aphasic subjects had fluent speech output. However, those with AD pathology had better processing speed than those with FTLD-U pathology. Immunohistochemistry with TDP-43 antibodies was negative. VBM revealed gray matter atrophy predominantly in the temporoparietal cortices, with notable sparing of the hippocampus in the aphasia with AD subjects. In comparison, the aphasic subjects with FTLD-U showed sparing of the parietal lobe. Typical AD subjects showed temporoparietal and hippocampal atrophy. CONCLUSIONS: A temporoparietal pattern of atrophy on MRI in patients with progressive fluent aphasia and relatively preserved processing speed is suggestive of underlying Alzheimer disease pathology rather than frontotemporal lobar degeneration with ubiquitin-only immunoreactive changes. GLOSSARY: AD = Alzheimer disease; ADPR = Alzheimer's Disease Patient Registry; ADRC = Alzheimer's Disease Research Center; aphasia-AD = subjects with progressive aphasia and Alzheimer disease pathology; aphasia-FTLD-U = subjects with progressive aphasia and frontotemporal lobar degeneration with ubiquitin-only immunoreactive changes pathology; CDR = Clinical Dementia Rating; DCT = discrete cosine transformation; FTLD = frontotemporal lobar degeneration; FTLD-U = frontotemporal lobar degeneration with ubiquitin-only immunoreactive changes; FWHM = full-width at half-maximum; GM = gray matter; MMSE = Mini-Mental State Examination; MNI = Montreal Neurological Institute; NA = not applicable; NIA = National Institute on Aging; NR = not reported; NS = not significant; PPA = primary progressive aphasia; typical AD = subjects with a clinical and pathologic diagnosis of Alzheimer disease; VBM = voxel-based morphometry; WAIS-R = Wechsler Adult Intelligence Scale-Revised; WM = white matter; WMS-R = Wechsler Memory Scale-Revised.

Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Publishing Authors By Initials

KA Josephs,JL Whitwell,JR Duffy,WA Vanvoorst,EA Strand,WT Hu,BF Boeve,NR Graff-Radford,JE Parisi,DS Knopman,DW Dickson,CR Jack,RC Petersen,KA Josephs,JL Whitwell,JR Duffy,WA Vanvoorst,EA Strand,WT Hu,BF Boeve,NR Graff-Radford,JE Parisi,DS Knopman,DW Dickson,CR Jack,RC Petersen,KA Josephs,JL Whitwell,JR Duffy,WA Vanvoorst,EA Strand,WT Hu,BF Boeve,NR Graff-Radford,JE Parisi,DS Knopman,DW Dickson,CR Jack,RC Petersen,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Neurology

VOLUME: 70

Page Numbers: 25-34

Journal Abbreviation: Neurology

ISSN: 1526-632X

DAY: 1

MONTH: Jan

YEAR: 2008

Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 401060

Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Progressive aphasia secondary to Alzheimer disease vs FTLD pathology.

AFFILIATION: Department of Neurology, Mayo Clinic, Rochester, MN 55905 josephs.keith@mayo.edu.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Neurology

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Progressive aphasia secondary to Alzheimer disease vs FTLD pathology Related Publications

• 4-Hydroxy-2-nonenal adduction of extracellular signal-regulated kinase (Erk) and the inhibition of hepatocyte Erk-Est-like protein-1-activating protein-1 signal transduction.
• A method for using blocked and event-related fMRI data to study "resting state" functional connectivity.
• Acute IGF-1 deficiency in multiple trauma victims.
• Bone marrow-derived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration.
• Botulinum toxin in dermatology - beyond wrinkles and sweat.
• Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial.
• Communication outcomes of critical imaging results in a computerized notification system.
• Distinct brain networks for adaptive and stable task control in humans.
• Dynamics and interaction of caveolin-1 isoforms with BMP-receptors.
• Echoendoscopes.
• Effect of cholesterol on the biophysical and physiological properties of a clinical pulmonary surfactant.
• Effects of ApoE genotype and mild cognitive impairment on implicit learning.
• Ethanol-induced modulation of hepatocellular extracellular signal-regulated kinase-1/2 activity via 4-hydroxynonenal.
• Evaluation of a proposed velocity equation for improved exothermic process control.
• Evidence for a stem cell hierarchy in the adult human breast.
• Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study.
• Health care funding levels and patient outcomes: a national study.
• Identifying diagnostic errors in primary care using an electronic screening algorithm.
• Implicit learning of sequential regularities and spatial contexts in corticobasal syndrome.
• Mitochondrial genetic polymorphisms and pancreatic cancer risk.
• Natural history of pain following herpes zoster.
• Non-disjunction of chromosome 13.
• Placebo-controlled comparison of a morphine/dextromethorphan combination with morphine on experimental pain and hyperalgesia in healthy volunteers.
• Re: Multiple Z-plasty in pilonidal sinus--a new technique under local anesthesia.
• Residue-specific adduction of tubulin by 4-hydroxynonenal and 4-oxononenal causes cross-linking and inhibits polymerization.
• Screening for congenital toxoplasmosis: accuracy of immunoglobulin M and immunoglobulin A tests after birth.
• The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
• Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells.
• Visual hallucinations in posterior cortical atrophy.
• [Surgical options in the treatment of rectal prolapse: indications, techniques and results]